IQVIA艾昆纬：2025年处方集控制对五个慢性病治疗领域商业保险患者的影响报告（英文版）

Commercial payers leverage formularies to manage prescription utilization and costs by employing control measures such as prior authorizations, step therapy, and formulary exclusions. These payer restrictions have increased over the past decade and can result in patients’ prescriptions being rejected at the pharmacy counter. Experiencing a rejection at the pharmacy can add layers of complexity to a patient’s treatment journey and can also lead to delayed or forgone care. To demonstrate how co